Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0273560 PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES
The present invention relates to a process for phospholipidation of imidazoquinolines and oxoadenines. More particularly, the present invention relates to a...
2018/0273559 GOLD COMPLEXES OF ALKYLATED PHOSPHINES
Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g....
2018/0273558 COMPOSITION CONTAINING A GOLD (I) COMPLEX AND CANCER CELLS
Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g....
2018/0273557 PROCESS FOR RECOVERING A MIXTURE COMPRISING A (THIO)PHOSPHORIC ACID DERIVATIVE
Provided herein is a use of a high-boiling solvent in a mixture comprising a (thio)phosphoric acid derivative and a process including the addition of a...
2018/0273556 Phosphate Ester Composition and Use
A phosphate ester composition comprising more than 50 mass % of a phosphate ester represented by Formula 1, wherein X, Y, and Z are independently selected from...
2018/0273555 METHOD FOR PREPARING RACEMIC OR OPTICALLY ACTIVED D- OR L-A-GLYCEROPHOSPHORYLCHOLINE SOLIDS
Racemic or optically active D- or L-.alpha.-glycerophosphoryl choline solids are prepared from liquid type racemic or optically active D- or ...
2018/0273554 NEW LIPOPHENOL COMPOUNDS AND USES THEREOF
The present invention relates to a compound of formula (I) wherein:--i is 0 or 1; j is 0 or 1; k is 0 or 1;--R.sub.1 and R.sub.2 are in particular H,...
2018/0273553 BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds,...
2018/0273552 BETA-LACTAMASE INHIBITORS
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit...
2018/0273551 PHARMACEUTICAL COMPOUNDS
Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty, acids, such as but not limited to lipoic acid, and pharmaceutical...
2018/0273550 METAL BICYCLIC AMIDINATES
Compounds are synthesized with bicyclic amidinate ligands attached to one or more metal atoms. These compounds are useful for the synthesis of materials...
2018/0273549 Broad Spectrum Beta-Lactamase Inhibitors
Broad spectrum beta-lactamase inhibitors. Certain inhibitors also exhibit potent antibiotic activity in addition to beta-lactamase inhibition. Compounds of the...
2018/0273548 NOVEL MACROCYCLIC SULFONDIIMINE COMPOUNDS
The present invention relates to novel macrocyclic sulfondiimine compounds of general formula (I) as described and defined herein, and methods for their...
2018/0273547 BROMODOMAIN INHIBITORS
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and...
2018/0273546 AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
The present invention relates to an amorphous solid form of (4S)-7-(3,5-dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-dihydroimidazo[1,5,- ...
2018/0273545 NUCLEATOR COMPOSITION COMPRISING SORBITOL ACETAL, SORBITOL DIACETAL AND SORBITOL TRIACETAL
The present invention provides a nucleator composition comprising sorbitol acetal, sorbitol diacetal, and sorbitol triacetal. The nucleator composition can...
2018/0273544 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
The invention features compounds (e.g., macrocyclic compounds) capable of modulating biological processes, for example through binding to a presenter protein...
2018/0273543 METHOD FOR PRODUCING LAMELLARIN AND DERIVATIVE THEREOF
The present application discloses a method for producing lamellarin and a derivative thereof, which is able to greatly shorten the synthesis path of the...
2018/0273542 Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other Gras Based Prodrugs Of Oxycodone And Uses Thereof
The invention describes pharmaceutical compounds and compositions comprised of a ligand attached to the opioid oxycodone, in a manner that substantially...
2018/0273541 NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
The present invention encompasses compounds of formula (I) ##STR00001## wherein the groups R.sup.1 to R.sup.4, R.sup.7, A, D, E, F, V, W, X, Y, n, r and q are...
2018/0273540 PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE
Certain pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds that inhibit cycline dependent kinase (CDK) (e.g., CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9,...
2018/0273539 NOVEL COELENTERAZINE COMPOUNDS AND USES THEREOF
There is provided a series of coelenterazine (CTZ) derivatives as a substrate with high luminescence intensity, which is optimal for maximum luminescence...
2018/0273538 PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS...
Compounds of formula (I): ##STR00001## wherein R.sub.1, R.sub.2, W.sub.3, W.sub.4, A.sub.1, and A.sub.2 are as defined in the description. Medicinal products...
2018/0273537 COMPOSITIONS AND METHODS FOR TREATING TOXOPLASMOSIS, CRYPTOSPORIDIOSIS AND OTHER APICOMPLEXAN PROTOZOAN RELATED...
The present disclosure is directed to compositions and methods for inhibiting either Toxoplasma gondii (T. gondii) calcium dependent protein kinases (TgCDPKs)...
2018/0273536 SMALL MOLECULES THAT BIND MR1
Disclosed are small molecules and pharmaceutical compositions comprising them that can be used in treating diseases associated with the major ...
2018/0273535 PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of...
2018/0273534 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES
Disclosed are compounds of formula (I) which possess nematicidal properties ##STR00001## wherein the structural elements have the meaning as indicated in the ...
2018/0273533 [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]IS- OQUINOLIN-2-YL]METHANOL AND...
Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: ##STR00001## wherein R.sub.1 is...
2018/0273532 TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS
Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and...
2018/0273531 PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] ##STR00001## ...
2018/0273530 PROCESS FOR PREPARING 1-(4-METHANESULFONYL-2-TRIFLUOROMETHYL-BENZYL)-2-METHYL-1H-PYRROLO ...
This invention relates to novel processes for synthesizing [1-(4-Methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b- ]pyridin-3-yl]-acetic acid...
2018/0273529 BICYCLIC COMPOUND AND USE THEREOF FOR INHIBITING SUV39H2
The present invention directs to a compound represented by formula (I).
2018/0273528 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Compounds of formula (I): ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are as defined in the description. Medicinal products containing...
2018/0273527 POTENT ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
The present technology provides compounds according to Formulas (I), (II), or (III) useful in inhibiting an enterovirus, paramyxovirus, respiratory virus,...
2018/0273526 CRYSTAL FORM OF PYRROLOQUINOLINE QUINONE SODIUM SALT AND PREPARATION METHOD AND USE THEREOF
Provided are crystal forms I, II, III and IV of a pyrroloquinoline quinone sodium salt and a preparation method thereof. Also provided are a pharmaceutical...
2018/0273525 Fused Pyridine Derivatives As Kinase Inhibitors
A series of substituted pyrido[3,2-d]pyrimidine and 1,5-naphthyridine derivatives of formula (I), as defined herein, being selective inhibitors of...
2018/0273524 PIPERAZINE-CONTAINING TWO-PHOTON ABSORBING COMPOUNDS
A two-photon absorbing (TPA) compound is provided along with a method of making same. The TPA compound has a general structural formula: ##STR00001## where...
2018/0273523 INHIBITORS OF KRAS G12C MUTANT PROTEINS
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): (I) or a pharmaceutically...
2018/0273522 SALTS AND SOLID FORMS OF A MONOBACTAM ANTIBIOTIC
The invention provides new solid forms, salts and polymorphs of 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazoli- ...
2018/0273521 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of...
2018/0273520 HEPATITIS B CORE PROTEIN MODULATORS
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of...
2018/0273519 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
Disclosed are compounds of Formula (I'), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The...
2018/0273518 4-HYDROXY-3-(HETEROARYL)PYRIDINE-2-ONE APJ AGONISTS
The present invention provides compounds of Formula (I): ##STR00001## wherein all variables are as defined in the specification, and compositions comprising any...
2018/0273517 COMPOUNDS USEFUL AS MODULATORS OF TRPM8
The present disclosure relates to compounds which are useful as cooling sensation compounds.
2018/0273516 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
The invention relates to 8-amino-2-oxo-1,3-diaza-spiro[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of...
2018/0273514 Series of Resveratrol-Derivative Fluorescently Labeled Molecules and Synthesis Method Thereof
The invention discloses a series of resveratrol-derivative fluorescently labeled molecules and a synthesis method thereof. The fluorescently labeled molecules...
2018/0273513 DICYANOPYRAZINE COMPOUND, LUMINESCENT MATERIAL, LUMINESCENCE DEVICE USING THE SAME, AND METHOD FOR PRODUCING...
A compound represented by formula (I) or formula (1I): ##STR00001## in formula (I), R.sup.3 represents an electron donating group, R.sup.4 represents a...
2018/0273512 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS
Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers,...
2018/0273511 BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a condition, disorder, or disease mediated by a lipid kinase or a...
2018/0273510 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
The present invention relates to a novel heterocyclic compound inhibiting a cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.